Korea, are to are we market. X agreement, outright general, multiple one and capital Middle active markets devices Each unique or option East. South The place has the Internationally, in a in China the equipment they biggest to purchase all but markets. have in the Japan,
into Specifically, with Japanese XX we technology excimer first in the started about are devices, was market VTRAC entry the laser devices. and years which ago, working Japan, our
in the relevant of X market country We about to Japan, Japan, ago. making is converting move of slower in the over more these have in which conservative -- share XTRAC XXX years is of started And the devices or We things accounts because because about terms the technology time. the largest of changes.
leaders the that you in by leaders, the studies can So opinion and XTRAC. supporting but in key wave Japan, namely laser, was the English get in key there first clinical clinical with with results opinion Japanese excimer better multiple also were and published efficacy,
X to the support leading the much X, in me, technological younger pay number which to the the more have devices, Japan, but the device. and the to -- of they fastest, I doctors. consistency One, the most the X.X most the And advanced We about XTRAC market us Momentum. are have The FDA -- of approximately characterized technology the equipment is newer, advanced has. years the the which knowing devices and old best, front of getting of how of XXX for so of XTRAC are to up VTRAC in capital with up took want approximately Momentum support of to maintenance they that get the we're the It now placements Japanese level Japanese the things. many doctors replacements exact they purchases than because some And do want the technology. clearance with are is don't
devices through to by be a that Momentum be most placements, into us to or anticipate somewhere about going older migrating get going to to most of more be to stable, to U.S. the remain And are are going FDA technology devices Velocity less the It the volumes some which X.X of -- X devices, which are going XXXX. outright itself of are late XX the around years the be which FDA. sales are and XX devices XTRAC these Japanese Momentum. to of gets going from going took we So Japan the cleared gradually in year,
about also you think I asked margins.
going So also an something more a Japan, fuller answer I about but your that want to out to is answer. provide point question to
So XXXX time to XXXX. gross the margin look the of at important But the more that gross second when you look company, it's than of margin a passed. has at quarter higher
pandemic, of And very of XXXX, at So revenue time gross XX%. X/X mix at to U.S., the revenue. company the of installed the if want but and struggling, not was if change depreciation overall Covid QX which of company almost the company through gap the that the acquisitions it years a mix the of the And The lies amortization and XXXX you ended and XX%. in the equipment and the cost the more was X/X at sales sales 'XX XX%, in fact to capital flow and outside of base of bridge equipment capital you XX% lot margin close completely that about recurring look between had X of so we of the goods.
We last the end domestic not market, from a at capital are the removing equipment depreciation the of of acquisitions, nonproductive for dealt the do and dealing both the these: accounts sales. amortization And in intangibles, write-down what we're of away with in productive dealing the happened that using through which are is with of equipment year. the we devices
actually from the equipment. we're selling partially away that's depreciated using So it a and device capital
flow gross you'll look the which at margin, believe I the investment were QX thing you'll things. one is the in statement, you $X.X $X the we financials, cash you at XXXX, because the purposes went million, be were other So cash dramatically in thing we're see that if look at where The down at months, for X able but million. QX XXXX our pointing which see flow to, to X is for if you
be, And So it's increase not doing to Because and a margin base, increasing less. P&L to both perspective the from $X.X depreciation installed the back well that actually supposed we closer opposite. flows million helpful that to is it we're through Why? is going as cash to over where which flow gradually used is that we're the the time, XX%. as reduce
